COSMOS Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
COSMOS Pharmaceutical has a total shareholder equity of ¥237.2B and total debt of ¥26.8B, which brings its debt-to-equity ratio to 11.3%. Its total assets and total liabilities are ¥485.0B and ¥247.8B respectively. COSMOS Pharmaceutical's EBIT is ¥33.6B making its interest coverage ratio 395.7. It has cash and short-term investments of ¥51.4B.
Key information
11.3%
Debt to equity ratio
JP¥26.82b
Debt
| Interest coverage ratio | 395.7x |
| Cash | JP¥51.42b |
| Equity | JP¥237.20b |
| Total liabilities | JP¥247.83b |
| Total assets | JP¥485.03b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CSMY.F's short term assets (¥156.4B) do not cover its short term liabilities (¥216.8B).
Long Term Liabilities: CSMY.F's short term assets (¥156.4B) exceed its long term liabilities (¥31.0B).
Debt to Equity History and Analysis
Debt Level: CSMY.F has more cash than its total debt.
Reducing Debt: CSMY.F's debt to equity ratio has increased from 6.3% to 11.3% over the past 5 years.
Debt Coverage: CSMY.F's debt is well covered by operating cash flow (205.7%).
Interest Coverage: CSMY.F's interest payments on its debt are well covered by EBIT (395.7x coverage).